1. Toxoplasmosis is caused by the protozoan Toxoplasma gondii and presents a high risk for fetuses, newborns, and immunocompromised individuals. Congenital toxoplasmosis results from maternal infection during pregnancy.
2. In immunocompromised patients, toxoplasmosis often occurs in those with impaired T cell-mediated immunity and presents as toxoplasmic encephalitis, pneumonia, or organ involvement.
3. Diagnosis involves antibody testing, parasite detection, imaging, and histology. Treatment consists of pyrimethamine and sulfadiazine with folate for acute infections or prophylaxis in high-risk groups.
There are nearly 100 viruses of the herpes group that infect many different animal species.
Official name of herpesviruses that commonly infect human is Humans herpesvirus (HHV)
herpes simplex virus types 1 (HHV 1)
Herpes simplex virus type 2 (HHV 2)
Varicella-zoster virus (HHV 3)
Epstein-Barr virus, (HHV 4)
Cytomegalovirus (HHV 5)
Human herpesvirus 6 (HHV 6)
Human herpesvirus 7 (HHV 7)
Human herpesvirus 8 (HHV 8) (Kaposi's sarcoma-associated herpesvirus).
Herpes B virus of monkeys can also infect humans
hELMINTHS#corona virus#Aspergillosis#BUGANDO#CUHAS#CUHAS#CUHAS
Infections and salivary gland disease in pediatric age: how to manage - Slide...WAidid
The slideset by Professor Susanna Esposito aims at explaining how to manage the salivary gland infections in pediatric age, from pathogenesis, to transmission, treatments and vaccination coverage, that should be urgently increased in Italy as well as in EU Countries.
There are nearly 100 viruses of the herpes group that infect many different animal species.
Official name of herpesviruses that commonly infect human is Humans herpesvirus (HHV)
herpes simplex virus types 1 (HHV 1)
Herpes simplex virus type 2 (HHV 2)
Varicella-zoster virus (HHV 3)
Epstein-Barr virus, (HHV 4)
Cytomegalovirus (HHV 5)
Human herpesvirus 6 (HHV 6)
Human herpesvirus 7 (HHV 7)
Human herpesvirus 8 (HHV 8) (Kaposi's sarcoma-associated herpesvirus).
Herpes B virus of monkeys can also infect humans
hELMINTHS#corona virus#Aspergillosis#BUGANDO#CUHAS#CUHAS#CUHAS
Infections and salivary gland disease in pediatric age: how to manage - Slide...WAidid
The slideset by Professor Susanna Esposito aims at explaining how to manage the salivary gland infections in pediatric age, from pathogenesis, to transmission, treatments and vaccination coverage, that should be urgently increased in Italy as well as in EU Countries.
toxoplasmosis is a disease caused by toxoplasma gondii parasite.. in this slides we can learn about their morphology, lifecycle, clinical features , laboratory diagnosis, treatment, prophylaxis, control.
toxoplasmosis is a disease caused by toxoplasma gondii parasite.. in this slides we can learn about their morphology, lifecycle, clinical features , laboratory diagnosis, treatment, prophylaxis, control.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
2. OVERVIEW
Toxoplasmosis is caused by infection with the
protozoan Toxoplasma gondii, an obligate
intracellular parasite.
Certain individuals, are at high risk of severe or life-
threatening disease due to this parasite.
These include congenitally infected fetuses, newborns
and immunologically impaired individuals
Congenital toxoplasmosis is the result of maternal
infection acquired during gestation.
3. In immunodeficient patients,toxoplasmosis
most often occurs in persons with defects
in T cell–mediated immunity such as those
receiving corticosteroids, anti–tumor
necrosis factor (TNF) therapies, or
cytotoxic drugs and those with malignance,
organ transplants, or acquired
immunodeficiency syndrome (AIDS).
4. In immunocompetent individuals, primary
or chronic (latent) infection with T. gondii is
asymptomatic; after the acute infection, a
small percentage has chorioretinitis,
lymphadenitis, or, even more rarely,
myocarditis and polymyositis
In 1983, the first report of toxoplasmosis in
AIDS patients appeared.Toxoplasmic
encephalitis (TE) subsequently was
recognized as the major cause of space-
occupying lesions in the brains
5. ETIOLOGY AND LIFE CYCLE
T. gondii is a coccidian parasite of felids
with humans and other warm blooded
animals serving as intermediate hosts.
It belongs to the subphylum Apicomplexa,
class Sporozoa
Its infectious frorms includes the oocyst,
the tachyzoites(group or claster of oocyst)
and tissue cyst (which contains and may
release bradyzoites),
6. Most organisms isolated from both
animals and humans can be grouped into
one of three clonal genotypes (types I to III)
Type III strains are common in animals but
observed significantly less often in cases
of human toxoplasmosis; most cases in
humans are caused by type II strains.
Both type I and II strains have been
associated with human congenital toxopl
7. 1. OOCYST
Cats sheds oocysts after they ingest any
of the three forms of the parasite, at which
time an enteroepithelial cycle begins.
This sexual form of reproduction begins
when the parasites penetrate the epithelial
cells of the small intestine and initiate
development of asexual and sexual
(gametogony) forms of the parasite.
Oocyst wall, oocysts are discharged into
the intestinal lumen by rupture of intestinal
epithelial cells.
8. 2. TACHYZOITE
Tachyzoites are seen in both primary and
reactivated infection; their presence is the
hallmark of active infection.
Once the tachyzoite has invaded the
target cell, it can undergo stage
conversion into the bradyzoite form.
9. 3. TISSUE CYST
Tachyzoites multiply rapidly and
synchronously, forming more slowly
replicating bradyzoites which forms tissue
cysts.
10. VIRULENCE FACTORS
Its anterior end consist Conoid assist
parasites entrace into host cells
Rhoptries which has secretory functions
for parasitic invasion.
It has Dense granules in its cytoplasm
which release parasitophorous
vacuole,which also assist its entry.
11.
12.
13.
14. The oocysts survive better in
environments with hot,humid climate
and lower altitude. Infection rate is
often highest in this area.
EPIDEMIOLOGY
15.
16.
17. T.gondii can favor mother to child transmission HCV,HBV and HIV
verticle transimmision.
According to this study,336 pregnant women were enrolled for
investigation on the presence of serum antibodies agaist
T.gondii,HCV,HBV and HIV using ELISA, the prevlance of
T.gondii,HCV and HBV was 25.3%,5.4%,9.8% respectively
HIV serostatus 61.6 % seems to be associated with greater
prevalance rate of both T. gondii 28.5% vs 20.2% and HBV 11.6%
vs 7%.
18. Untreated T.gondii infection are often fatal in AIDS patients, IgG
agglutination and PCR was used to analyse blood samples from
130 HIV positive patient in Uganda.
Anti T.gondii were detected in 54% of the patient,while 23% had
parasites in the paripheral blood.
19. This study reveals 30.9% of 350 pregnant women were
seropositive for toxoplasma gondii specific antibodies
20.
21. The Study done by Elichilla Shao et al
‘sero-prevalence and factors associated
with Toxoplasma gondii infection among
pregnant women antending ANC at KCMC
in 2015 revealed 60 of 144(41.7%)
pregnant women were seropostive for
T.gondii specific Abs
22. PATHOGENESIS
Attachment to the host cell membrane
requires the calcium-dependent secretion of
adhesins.
T. gondii multiplies intracellularly at the site
of invasion (the gastrointestinal tract is the
major route for and the initial site of
infection in nature)
Invasion is an active process relying on
parasite motility and the sequential
secretion of proteins from secretory
23. Organisms may spread first to the
mesenteric lymph nodes and then to
distant organs by invasion of lymphatics
and blood
Tissue cyst formation takes place in
multiple organs and tissues during the first
week of infection, which are responsible
for chronic or residual or latent infection
and persists primarily in the brain, skeletal
and heart muscle, and eye.
24. In immunocompetent individuals, the initial
infection and the resultant seeding of
different organs lead to a chronic or latent
infection without clinical significance
Toxoplasmosis in immunodeficient
individuals may be caused by primary
infection
It most often is the result of reactivation of
a latent infection.
25. It is widely held that reactivation is the
result of disruption of the tissue cyst form
followed by uncontrolled proliferation of
organisms and tissue destruction.
After invasion, the humoral and cellular
immunity become activated
Only those parasites protected by an
intracellular habitat or within tissue cysts
survive.
26. An effective immune response reduces
the number of tachyzoites in all tissues.
Tachyzoites are killed by reactive oxygen
intermediates,acidification,osmotic
fluctuations and reactive nitrogen
intermediates and specific antibody
combined with complement
27. PATHOLOGY 1/3
CENTRAL NERVOUS SYSTEM
•Damage to the CNS
o Multiple foci of enlarging necrosis and microglial
nodules.
o Periaqueductal and periventricular vasculitis with
necrosis
•Hydrocephalus
o Obstruction of the aqueduct of Sylvius or foramen
of Monro.
•Multiple brain abscesses
• Severely immunodeficient
28. EYE
•Chorioretinitis in AIDS patients is characterized by segmental
panophthalmitis and areas of coagulative necrosis associated with
tissue cysts and tachyzoites
LUNGS
•Interstitial pneumonitis, necrotizing pneumonitis, consolidation,
pleural effusion, empyema, or all of these.
SKELETALAND HEART MUSCLES
•Myositis & Myocarditis has been reported in some HIV-infected
patients who present with neuromuscular symptoms
LYMPH NODES
•Frequently distinctive and often diagnostic, a reactive follicular
hyperplasia is seen always
PATHOLOGY 2/3
29. CLINICAL FEATURES 1/2
Imunocompetent patients
• Only 10% to 20% of cases of T. gondii infection in adults
and children are symptomatic, benign and self-limited
(Symptoms, if present, usually resolve within a few
months)
• Cervical lymphadenopathy discrete and nontender, are
rarely greater than 3 cm in diameter, may vary in
firmness, and do not suppurate.The nodes may be tender
or matted.
• Fever, malaise, night sweats, myalgias, sore throat,
maculopapular rash, hepatosplenomegaly, and small
numbers of atypical lymphocytes (<10%) may be present.
30. Immunocompromised Patients
• In HIV-infected patients, the incidence of toxoplasmosis is
closely related to CD4 T cell counts, with an increasing risk
when the count falls under 100 cells/l.
• Toxoplasmic encephalitis (TE):
o Most predominant manifestation, symptoms ranging from
headache,lethargy, incoordination, or ataxia to hemiparesis, loss of
memory, dementia, or focal to major motor seizures, usually associated
with fever
• Other organs: lungs, the eyes, and the heart, but the isolation
of Toxoplasma from many other sites, such as liver, pancreas,
bone marrow, bladder, lymph nodes, kidney, spleen, and skin
has been documented
CLINICAL FEATURES 2/2
31. • Classically, Primary acquired maternal infection during
gestation.
• Risk
• Less than 10%, 30%, 60-70% of cases during the first
trimester, 2nd and 3rd Trimester respectively
• Major sequelae:
o Mental retardation, seizures, microcephalus ,
hydrocephalus, deafness, and psychomotor deficiency.
o Eye: Microphthalmia, cataract, increased intraocular
pressure, strabismus, optic neuritis, and retinal necrosis,
uveitis and retinochoroiditis can be observed
• Characteristic triad: Chorioretinitis, Hydrocephalus and
Cerebral calcification
Congenital toxoplasmosis
33. Isolation
• Mouse inoculation or inoculation in tissue
cell cultures
• Isolation of T. gondii from blood or body
fluids establishes that the infection is acute
34. Histio & Cytopathology
Cytology
Eg CSF, BAL, Amniotic fluid
• Tachyzoites may be identified
Tissue biopsy (H&E) - Difficult
immunohistiochemistry- better
• Multiple tissue cysts near an inflammatory
necrotic lesion
35. Imaging Studies
CT scanning in cerebral toxoplasmosis
(general)
•Multiple bilateral cerebral lesions but may be
solitary.
MRI has superior sensitivity
Ultrasonography
•Ultrasonographic diagnosis of congenital
toxoplasmosis in a fetus is available at 20-24
weeks' gestation.
37. Treatment 1/3
Acute infection
•Sulphadiazine tabs 1 gm 6 hourly +
Pyrimethamine tabs 100mg loading dose, then
50mg /day + Folic acid tabs 10mg /day for 6
weeks.
•Clindamycin capsules 450mg -600mg 6 hourly
+ Pyrimethamine tabs 100mg loading dose, then
50mg /day for 6 weeks.
Source: Tanzania, National guidelines for the management of HIV and AIDS
38. Treatment 2/3
After six weeks of treatment
• Give prophylaxis therapy with Sulphadiazine
tabs 500mg 6 hourly + Pyrimethamine tabs 25-
50mg /day + Folic acid tabs 10mg /day.
For those allergic to sulphur replace
Sulphadiazine tabs with Clindamycin capsules
450mg 6 hourly
• Discontinue maintenance therapy when CD4
count is >200cells/ml, initial therapy is
completed and patient is asymptomatic.
Source: Tanzania, National guidelines for the management of HIV and AIDS
39. • Primary prophylaxis therapy for toxoplasmosis
can be accomplished with Trimethoprim–
Sulphamethoxazole (TMP-SMX) tabs
160/800mg administered orally/day.
• For those allergic to sulphur, give Dapsone
tabs 50mg/day + Pyrimethamine tabs 50mg per
week + Folic Acid tabs 10mg 3 times a week
Treatment 3/3
41. • Treatment of pregnant women to reduce parasite
transmission.
• Screening
o Prenatal screening and treatment to limit fetal damage.
o Postnatal screening of neonates to promote early
treatment.
o Screening Immunocompromised Patients
• Prophylaxis of TE in Toxoplasma-seropositive AIDS
patients is rather consensual, and Cotrimoxazole
prophylaxis should be administered when the CD4 T cell
count falls below 100 cells/l. since it is also suited
for(PCP) prophylaxis.
Secondary Prevention
42. REFERENCES
• Mandell,Bennett &Dolin,Principels and Practice of Infectious Diseases 6th
edition
• Epidemiology of and Diagnostic Strategies for Toxoplasmosis-Florence
Robert-Gangneuxa,b and Marie-Laure Dardéc 2012
• Sero-prevalence and factors associated with Toxoplasma gondii infection
among pregnant women attending antenatal care in Mwanza, Tanzania-
Mwambe et al. Parasites & Vectors 2013, 6:222
• High seroprevalence of specific Toxoplasma gondii IgG antibodies among
HIV/AIDS patients with immunological failure attending a tertiary hospital
in northwestern Tanzania-Mirambo et al 2013
• Sero-Prevalence and Factors Associated with Toxoplasma Gondii Infection
among Pregnant Women Attending Antenatal Care in the Referral Hospital
in Tanzania: Cross Sectional Study-Shao et al 2014
• Tanzania, National guidelines for the management of HIV and AIDS, 7th
Edition, 2019
Antibodies can be detected by ELISA or ISAGAs and Indirect Fluorescent antibody Test(IFAT)
Amniopuncture at 16wks of GA or atleast 4wks after maternal infection
Sabin-Feldman test detects IgG as early as 1-2 weeks,reaching peak at 6-8 weeks and then gradually decline over 1 to 2 years.It needs an alive organism.